|
2007 Journal Article Early to moderate chronic kidney diseaseMathew, Tim and Johnson, David (2007). Early to moderate chronic kidney disease. Medical Observer. |
|
2007 Journal Article Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injuryGobe, Glenda C. and Johnson, David W. (2007). Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. The International Journal of Biochemistry & Cell Biology, 39 (9), 1551-1561. doi: 10.1016/j.biocel.2007.04.025 |
|
2007 Journal Article Prevention of progression of kidney disease: CARI guidelinesJohnson, David W. (2007). Prevention of progression of kidney disease: CARI guidelines. Australian Family Physician, 36 (5), 353-353. |
|
2007 Journal Article How to treat: Resistant hypertensionJohnson, David W. (2007). How to treat: Resistant hypertension. Australian Doctor, 20, 27-28, 30-32, 34. |
|
2007 Journal Article Resistant hypertensionJohnson D.W. (2007). Resistant hypertension. Australian Doctor (20/APR) |
|
2007 Journal Article Drug dosing adjustment in people with reduced GFRMathew, Timothy, Jones, Graham and Johnson, David (2007). Drug dosing adjustment in people with reduced GFR. Australian Prescriber, 30 (2), 34-34. |
|
2007 Journal Article Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x |
|
2007 Journal Article Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidneyVesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x |
|
2007 Journal Article Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x |
|
2007 Journal Article The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantationHourigan, M. J., Mollee, P. N., Gill, D. S., Doecke, J., Norris, D., Johnson, D. W. and Gandhi, M. K.. (2007). The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation. American Journal of Transplantation, 7, 399-399. |
|
2007 Journal Article Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factorsOrazio, Linda, Armstrong, Kirsty, Banks, Merrilyn, Johnson, David, Isbel, Nikky and Hickman, Ingrid (2007). Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors. Nutrition & Dietetics, 64 (3), 200-206. doi: 10.1111/j.1747-0080.2007.00151.x |
|
2007 Journal Article Modification of cardiovascular risk in hemodialysis patients: an evidence-based reviewJohnson, David W., Craven, Ann-Maree and Isbel, Nicole Maree (2007). Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodialysis International, 11 (1), 1-14. doi: 10.1111/j.1542-4758.2007.00146.x |
|
2007 Journal Article Update for GPs on the management of mild to moderate renal impairment.Mathew, T. and Johnson, D. (2007). Update for GPs on the management of mild to moderate renal impairment.. Medical Observer, 31-34. |
|
2007 Journal Article Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysisCraven, Ann-Maree S., Hawley, Carmel M., McDonald, Stephen P., Rosman, Johan B., Brown, Fiona G. and Johnson, David W. (2007). Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis. Peritoneal Dialysis International, 27 (2), 184-191. doi: 10.1177/089686080702700216 |
|
2007 Journal Article Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigsForman, Colin J., Johnson, David W. and Nicol, David L. (2007). Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU International, 99 (1), 162-165. doi: 10.1111/j.1464-410X.2006.06505.x |
|
2007 Journal Article Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysisVan Eps, Carolyn, Jeffries, Janine K., Anderson, John A., Bergin, Patrick T., Johnson, David W., Campbell, Scott B., Carpenter, Sally M., Isbel, Nicole M., Mudge, David W. and Hawley, Carmel M. (2007). Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology, 12 (3), 224-233. doi: 10.1111/j.1440-1797.2006.00712.x |
|
2007 Journal Article Evaluation of renal function: CARI guidelinesJohnson, David W. (2007). Evaluation of renal function: CARI guidelines. Australian Family Physician, 36 (1-2), 46-46. |
|
2007 Journal Article Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concernsGobe, Glenda C., Endre, Zoltan H. and Johnson, David W. (2007). Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns. Drug Discovery Today: Therapeutic Strategies, 4 (1), 79-84. doi: 10.1016/j.ddstr.2007.07.001 |
|
2006 Journal Article Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell linesMorais, Christudas, Pat, Betty, Gobe, Glenda, Johnson, David W. and Healy, Helen (2006). Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrology Dialysis Transplantation, 21 (12), 3377-3388. doi: 10.1093/ndt/gfl543 |
|
2006 Journal Article Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysisTeigen, Mette Maja B., Duffull, Stephen, Dang, Lily and Johnson, David W. (2006). Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. Journal of Clinical Pharmacology, 46 (11), 1259-1267. doi: 10.1177/0091270006292987 |
